The U.S. Food and Drug Administration (FDA) has approved Merilog, a biosimilar to the widely used insulin product Novolog (insulin aspart), to ... is a rapid-acting human insulin analog designed ...

vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension and 30% insulin as part injection (rDNA origin) pen fill ...

A Sanofi subsidiary has claimed FDA approval for the first biosimilar of Novo Nordisk's Novolog, an older formulation of the Danish pharma's blockbuster insulin analogue product insulin aspart.

Biocon Biologics and Civica, Inc. on Thursday announced a strategic collaboration agreement to expand access and affordability of Insulin Aspart in ... prefilled pens and vials of insulin ...

According to the company, this collaboration aims to enhance access and affordability of Insulin Aspart in the US. Shreehas Tambe, CEO & Managing Director, Biocon Biologics Ltd, stated ...

Virginia to produce prefilled pens and vials of insulin." This collaboration is in addition to Biocon Biologics' own Insulin Aspart Drug Product for the United States which is currently under U.S ...